Treatment Action Group: An activist’s guide to treatment for drug-resistant tuberculosis

Organisation: Position: Deadline Date: Location:

The 2020 updates to the World Health Organisation (WHO) guidelines shifted the global standard of care for drug-resistant TB in a number of important ways.

Our publication, An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis, details these shifts and other important information about the new global standard of care for drug-resistant TB, and provides messaging and strategies activists can use to advocate for improved access to WHO-recommended regimens and the new and repurposed medicines contained therein.

Our guide unpacks the latest WHO guidelines and supporting evidence bases, and breaks down what activists and communities affected by drug-resistant TB need to know to take action, overcome resistance, and hold governments and other actors accountable for ensuring equitable access to the best available standard of care for drug-resistant TB.

 

Treatment Action Group material

 

Guidelines

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.